Our earlier research demonstrated that p53, which is phosphorylated at Ser6 by JUNK1/2 kinases, form complexes with PARP1, which promotes the expression of CEGRs/ALCDs-dependent genes in patients with aggressive HBL [18,19]. This evidence concerns the gene PARP1 and hepatoblastoma.